Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuki Ichikawa

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
Clinical Transplantation|November 29, 2022
Regular protocol liver biopsy is useful to adjust immunosuppressant dose after adult liver transplantationShohei Narita, Satoshi Miuma, Sadayuki Okudaira, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 16, 2020
Calculated body muscle mass as a useful screening marker for low skeletal muscle mass and sarcopenia in chronic liver diseaseTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
Internal Medicine (Tokyo, Japan)|January 11, 2019
Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus InfectionTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
The American Journal of Gastroenterology|October 10, 2006
Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patientsNaota Taura, Tatsuki Ichikawa, Keisuke Hamasaki, et al.
Oncology Reports|September 14, 2006
Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: long-term trends in JapanNaota Taura, Keisuke Hamasaki, Kazuhiko Nakao, et al.
Biomedical Reports|February 12, 2020
Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver diseaseTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
Virology Journal|February 17, 2012
Paradoxical expression of IL-28B mRNA in peripheral blood in human T-cell leukemia virus type-1 mono-infection and co-infection with hepatitis C virusShimeru Kamihira, Tetsuya Usui, Tatsuki Ichikawa, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 16, 2012
Human T-cell leukemia virus type 1 infection worsens prognosis of hepatitis C virus-related living donor liver transplantationTatsuki Ichikawa, Naota Taura, Hisamitsu Miyaaki, et al.
Biomedical Reports|March 18, 2021
Comparison of calculated body muscle mass and SARC-F as methods of screening for sarcopenia in patients with chronic liver diseaseTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
Biomedical Reports|December 13, 2021
Change in tartrate-resistant acid phosphatase isoform 5b levels, a marker of bone metabolism, in patients with chronic hepatitis B treated with tenofovir alafenamideTakuma Okamura, Tatsuki Ichikawa, Hisamitsu Miyaaki, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Clinical Transplantation|November 29, 2022
Regular protocol liver biopsy is useful to adjust immunosuppressant dose after adult liver transplantationShohei Narita, Satoshi Miuma, Sadayuki Okudaira, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 16, 2020
Calculated body muscle mass as a useful screening marker for low skeletal muscle mass and sarcopenia in chronic liver diseaseTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
Internal Medicine (Tokyo, Japan)|January 11, 2019
Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus InfectionTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
The American Journal of Gastroenterology|October 10, 2006
Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patientsNaota Taura, Tatsuki Ichikawa, Keisuke Hamasaki, et al.
Oncology Reports|September 14, 2006
Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: long-term trends in JapanNaota Taura, Keisuke Hamasaki, Kazuhiko Nakao, et al.
Biomedical Reports|February 12, 2020
Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver diseaseTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
Virology Journal|February 17, 2012
Paradoxical expression of IL-28B mRNA in peripheral blood in human T-cell leukemia virus type-1 mono-infection and co-infection with hepatitis C virusShimeru Kamihira, Tetsuya Usui, Tatsuki Ichikawa, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 16, 2012
Human T-cell leukemia virus type 1 infection worsens prognosis of hepatitis C virus-related living donor liver transplantationTatsuki Ichikawa, Naota Taura, Hisamitsu Miyaaki, et al.
Biomedical Reports|March 18, 2021
Comparison of calculated body muscle mass and SARC-F as methods of screening for sarcopenia in patients with chronic liver diseaseTatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, et al.
Biomedical Reports|December 13, 2021
Change in tartrate-resistant acid phosphatase isoform 5b levels, a marker of bone metabolism, in patients with chronic hepatitis B treated with tenofovir alafenamideTakuma Okamura, Tatsuki Ichikawa, Hisamitsu Miyaaki, et al.
Pageof 15